Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants

Pharmacogenetics

Volumn 9, Issue 5, 1999, Pages 561-568

  Jovanovic, Vera ^a   Guan, Hong Chang ^a   Van Tol, Hubert H M ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

D4 receptor; Dopamine; Human; Polymorphism

Indexed keywords

ADRENALIN; DOPAMINE; DOPAMINE 4 RECEPTOR; NORADRENALIN;

ANIMAL CELL; ARTICLE; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; RECEPTOR AFFINITY; TANDEM REPEAT; VARIABLE NUMBER OF TANDEM REPEAT;

ANIMALIA;

EID: 0032738792     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199910000-00003     Document Type: Article

References (31)

1. Ariano MA, Wang J, Noblett KL, Larson ER, Sibley DR. Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res 1997; 752:26-34.
2. Asghari V, Schoots O, van Kats S, Ohara V, Jovanovic V, Guan HC, et al. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes. Mol Pharmacol 1994; 46:364-373.
3. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 1995; 65:1157-1165.
4. Bennett ST, Lucassen AM, Gough SC, Powell EE, Undlien DE, Pritchard LE, et al. Susceptibility to human type I diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus [see comments]. Nat Genet 1995; 9:284-292.
5. Bunzow JR, Van Tol HH, Grandy DK, Albert P, Salon J, Christie M, et al. Cloning and expression of a rat D2 dopamine receptor cDNA [see comments]. Nature 1988; 336:783-787.
6. Chang FM, Kidd JR, Livak KJ, Pakstis AJ, Kidd KK. The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Hum Genet 1996; 98:91-101.
7. Dal Toso R, Sommer B, Ewert M, Herb A, Pritchett DB, Bach A, et al. The dopamine D2 receptor: two molecular forms generated by alternative splicing. Embo J 1989; 8:4025-4034.
8. Guiramand J, Montmayeur JP, Ceraline J, Bhatia M, Borrelli E. Alternative splicing of the dopamine D2 receptor directs specificity of coupling to G-proteins. J Biol Chem 1995; 270:7354-7358.
9. Hayes G, Biden TJ, Selbie LA, Shine J. Structural subtypes of the dopamine D2 receptor are functionally distinct: expression of the cloned D2 A and D2B subtypes in a heterologous cell line. Mol Endocrinol 1992; 6:920-926.
10. Lanau F, Zenner MT, Civelli O, Hartman DS. Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor. J Neurochem 1997; 68:804-812.
11. Lichter JB, Barr CL, Kennedy JL, Van Tol HH, Kidd KK, Livak KJ. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet 1993; 2:767-773.
12. Liu YF, Civelli O, Grandy DK, Albert PR. Differential sensitivity of the short and long human dopamine D2 receptor subtypes to protein kinase C. J Neurochem 1992: 59:2311-2317.
13. Marder SR, Wirshing WC, Van Putten T. Drug treatment of schizophrenia. Overview of recent research. Schizophr Res 1991; 4:81-90.
14. Montmayeur JP, Guiramand J, Borrelli E. Preferential coupling between dopamine D2 receptors and G-proteins. Mol Endocrinol 1993; 7:161-170.
15. Mrzljak L, Bergson C, Pappy M, Huff R, Levenson R, Goldman-Rakic PS. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 1996; 381:245-248.
16. Munson PJ, Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 107:220-239.
17. Newman-Tancredi A, Audinot-Bouchez V, Gobert A, Millan MJ. Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors. Eur J Pharmacol 1997; 319:379-383.
18. Paterson A. All alleles are equal, but some alleles are more equal than others [letter; comment]. Mol Psychiatry 1998; 3:212.
19. Paterson AD, Sunohara GA, Kennedy JL. The dopamine D4 receptor: novelty or nonsense. Neuropsychopharmacology 1999; 21(1): 3-16.
20. Primus RJ, Thurkauf A, Xu J, Yevich E, McInerncy S, Shaw K, et al. II, Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1. J Pharmacol Exp Ther 1997; 282:1020-1027.
21. Rubinstein M, Phillips TJ, Bunzow JR, Falzone TL, Dziewczapolski G, Zhang G, et al. Mice lacking dopamine D4 receptors are super-sensitive to ethanol, cocaine, and methamphetamine. Cell 1997; 90:991-1001.
22. Sanyal S, Van Tol HH. Dopamine D4 receptor-mediated inhibition of cyclic adenosine 3′,5′-monophosphate production does not affect prolactin regulation. Endocrinology 1997; 138:1871-1878.
23. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1987; 1:133-152.
24. Seeman P, Van Tol HH. Dopamine receptor pharmacology. Curr Opin Neurol Neurosurg 1993; 6:602-608.
25. Seeman P, Van Tol HH. Dopamine receptor pharmacology. Trends Pharmacol Sci 1994; 15:264-270.
26. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990; 347:146-151.
27. Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G, et al. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 1991; 350:614-619.
28. Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 1991; 350:610-614.
29. Van Tol HH, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O. et al. Multiple dopamine D4 receptor variants in the human population [see comments]. Nature 1992; 358:149-152.
30. Wilson JM, Sanyal S, Van Tol HH. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action. Eur J Pharmacol 1998; 351:273-286.
31. Zhou QY, Grandy DK, Thambi L, Kushner JA, Van Tol HH, Cone R, et al. Cloning and expression of human and rat D1 dopamine receptors. Nature 1990; 347:76-80.